SinoMab BioScience Limited (3681.HK)

HKD 1.23

(4.24%)

Operating Income Summary of SinoMab BioScience Limited

SinoMab BioScience Limited's latest annual operating income in 2023 was -229.57 Million CNY , up 11.34% from previous year.
SinoMab BioScience Limited's latest quarterly operating income in 2024 Q2 was -84.64 Million CNY , down 0.0% from previous quarter.
SinoMab BioScience Limited reported an annual operating income of -258.92 Million CNY in 2022, up 15.34% from previous year.
SinoMab BioScience Limited reported an annual operating income of -305.85 Million CNY in 2021, down -88.04% from previous year.
SinoMab BioScience Limited reported a quarterly operating income of -120.15 Million CNY for 2023 Q4, down 0.0% from previous quarter.
SinoMab BioScience Limited reported a quarterly operating income of -109.42 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of SinoMab BioScience Limited (2023 - 2017)

Historical Annual Operating Income of SinoMab BioScience Limited (2023 - 2017)

Year	Operating Income	Operating Income Growth
2023	-229.57 Million CNY	11.34%
2022	-258.92 Million CNY	15.34%
2021	-305.85 Million CNY	-88.04%
2020	-162.65 Million CNY	40.63%
2019	-273.94 Million CNY	-399.91%
2018	-54.79 Million CNY	-38.4%
2017	-39.59 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-84.64 Million CNY	0.0%
2023 Q4	-120.15 Million CNY	0.0%
2023 Q2	-109.42 Million CNY	0.0%
2023 FY	-229.57 Million CNY	11.34%
2022 FY	-258.92 Million CNY	15.34%
2022 Q4	-150.4 Million CNY	0.0%
2022 Q2	-108.52 Million CNY	0.0%
2021 Q2	-122.84 Million CNY	0.0%
2021 Q4	-183.01 Million CNY	0.0%
2021 FY	-305.85 Million CNY	-88.04%
2020 Q2	-97.84 Million CNY	0.0%
2020 FY	-162.65 Million CNY	40.63%
2020 Q4	-64.8 Million CNY	0.0%
2019 Q2	-44.79 Million CNY	35.05%
2019 FY	-273.94 Million CNY	-399.91%
2019 Q4	-231.08 Million CNY	0.0%
2019 Q1	-68.97 Million CNY	0.0%
2018 Q1	-13.69 Million CNY	0.0%
2018 FY	-54.79 Million CNY	-38.4%
2018 Q4	-68.97 Million CNY	0.0%
2018 Q2	-13.69 Million CNY	0.0%
2017 FY	-39.59 Million CNY	0.0%
2017 Q1	-9.89 Million CNY	0.0%
2017 Q2	-9.89 Million CNY	0.0%
2017 Q4	-13.69 Million CNY	0.0%
2016 Q4	-9.89 Million CNY	0.0%

Peer Operating Income Comparison of SinoMab BioScience Limited

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	438.766%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	125.566%